Novartis
Novartis is reimagining medicine to improve and extend people’s lives. As a leading global medicines company, we use innovative science and digital technologies to create transformative treatments in areas of great medical need. In our quest to find new medicines, we consistently rank among the world’s top companies investing in research and development. Novartis products reach nearly 800 million people globally and we are finding innovative ways to expand access to our latest treatments. About 109,000 people of more than 145 nationalities work at Novartis around the world. Find out more at https://www.novartis.com.
Why We Are Here
What Challenge will you solve today?
Explore all our Challenges
Increasing Awareness and Testing of a Genetic Risk Factor for Cardiovascular Disease
According to the World Health Organization, cardiovascular diseases (CVDs) are the leading cause of death worldwide.
Development of a Systems Pharmacology Model
Studying the pharmacological effects of drugs injected into the human eye is difficult because traditional sampling methods are invasive. Therefore, the Seeker desires a computational model that accurately simulates the systems pharmacology of an administered drug.
Hypothesis for Causality
An approved medicine has been associated with post-marketing adverse event case reports following administration of the drug in the eye. Novartis is seeking plausible hypotheses for these observations based upon publicly available information.
Here's how the Challenge process works:
Register
Sign up and complete your Solver profile
Review & Accept
Read the description of the Open Challenges in the Challenge Center and accept the Challenge Specific Agreement
Submit
Upload proposed solution(s) you have developed for a specific Challenge
Win
Receive cash awards for solutions accepted by Seeker organizations
Join Novartis Oncology at the latest medical congresses
Learn how Novartis is pushing the boundaries with bold science, seeking to transform lives and striving toward cures for patients.
Novartis COVID-19 Information Center
Novartis is responding to the coronavirus disease (COVID-19) outbreak. The information center provides a central hub for news, guidance and resources.
Innovating for challenging healthcare issues
Data and Digital
Embedding data science and digital technologies across Novartis to transform the way we innovate in R&D, run our business operations and engage with HCPs and patients.
Cell & Gene Therapy at Novartis
Our teams aim to deliver on the promise of cell and gene therapy for patients.
Patients & Caregivers
We discover and develop breakthrough treatments and find new ways to deliver them to as many people as possible.
Healthcare Professionals
We work closely with healthcare professionals around the world to understand their unmet needs and create innovative programs to support their work.